Abstract
Continuous gradients exist at osteochondral interfaces, which may be engineered by applying spatially patterned gradients of biological cues. In the present study, a protein-loaded microsphere-based scaffold fabrication strategy was applied to achieve spatially and temporally controlled delivery of bioactive signals in three-dimensional (3D) tissue engineering scaffolds. Bone morphogenetic protein-2 and transforming growth factor-β1-loaded poly(d,l-lactic-co-glycolic acid) microspheres were utilized with a gradient scaffold fabrication technology to produce microsphere-based scaffolds containing opposing gradients of these signals. Constructs were then seeded with human bone marrow stromal cells (hBMSCs) or human umbilical cord mesenchymal stromal cells (hUCMSCs), and osteochondral tissue regeneration was assessed in gradient scaffolds and compared to multiple control groups. Following a 6-week cell culture, the gradient scaffolds produced regionalized extracellular matrix, and outperformed the blank control scaffolds in cell number, glycosaminoglycan production, collagen content, alkaline phosphatase activity, and in some instances, gene expression of major osteogenic and chondrogenic markers. These results suggest that engineered signal gradients may be beneficial for osteochondral tissue engineering.
Similar content being viewed by others
References
An, Y., and K. Martin. Handbook of Histology Methods for Bone and Cartilage. Humana Press, 2003.
Baksh, D., R. Yao, and R. S. Tuan. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384–1392, 2007.
Batycky, R., J. Hanes, R. Langer, and D. Edwards. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 86:1464–1477, 1997.
Berkland, C., K. Kim, and D. W. Pack. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J. Controlled Rel. 73:59–74, 2001.
Berkland, C., K. Kim, and D. W. Pack. PLG microsphere size controls drug release rate through several competing factors. Pharm. Res. 20:1055–1062, 2003.
Bianco, P., L. Fisher, M. Young, J. Termine, and P. Robey. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 49:421–426, 1991.
Botchwey, E. A., S. R. Pollack, S. El-Amin, E. M. Levine, R. S. Tuan, and C. T. Laurencin. Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology 40:299–306, 2003.
Botchwey, E. A., S. R. Pollack, E. M. Levine, and C. T. Laurencin. Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system. J. Biomed. Mater. Res. 55:242–253, 2001.
Boyan, B. D., Z. Schwartz, L. F. Bonewald, and L. D. Swain. Localization of 1,25-(OH)2D3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J. Biol. Chem. 264:11879–11886, 1989.
Boyden, S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 115:453–466, 1962.
Cao, X., and M. S. Shoichet. Investigating the synergistic effect of combined neurotrophic factor concentration gradients to guide axonal growth. Neuroscience 122:381–389, 2003.
Choi, S., J. Kim, E. Kang, S. Lee, M. Park, Y. Park, and S. Lee. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis. Rheumatology 47:1775–1779, 2008.
Ciavarella, S., F. Dammacco, M. De Matteo, G. Loverro, and F. Silvestris. Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. Stem Cells Dev. 18:1211–1220, 2009.
Dickhut, A., V. Dexheimer, K. Martin, R. Lauinger, C. Heisel, and W. Richter. Chondrogenesis of human mesenchymal stem cells by local TGF-beta delivery in a biphasic resorbable carrier. Tissue Eng. A 16(2):453–464, 2010.
Dodla, M. C., and R. V. Bellamkonda. Anisotropic scaffolds facilitate enhanced neurite extension in vitro. J. Biomed. Mater. Res. A 78:213–221, 2006.
Edwards, C., and W. O’Brien, Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta 104:161–167, 1980.
Eufinger, H., C. Rasche, J. Lehmbrock, M. Wehmoller, S. Weihe, I. Schmitz, C. Schiller, and M. Epple. Performance of functionally graded implants of polylactides and calcium phosphate/calcium carbonate in an ovine model for computer assisted craniectomy and cranioplasty. Biomaterials 28:475–485, 2007.
Gerstenfeld, L. C., J. Cruceta, C. M. Shea, K. Sampath, G. L. Barnes, and T. A. Einhorn. Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J. Bone Miner. Res. 17:221–230, 2002.
Gordeladze, J., F. Djouad, J. Brondello, D. Noël, I. Duroux-Richard, F. Apparailly, and C. Jorgensen. Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs. Acta Pharmacol. Sin. 30:1369–1384, 2009.
Guo, X., H. Park, G. Liu, W. Liu, Y. Cao, Y. Tabata, F. K. Kasper, and A. G. Mikos. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 30:2741–2752, 2009.
Heng, B. C., T. Cao, and E. H. Lee. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells 22:1152–1167, 2004.
Hersel, U., C. Dahmen, and H. Kessler. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24:4385–4415, 2003.
Holland, T. A., E. W. Bodde, L. S. Baggett, Y. Tabata, A. G. Mikos, and J. A. Jansen. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J. Biomed. Mater. Res. A 75:156–167, 2005.
Holland, T. A., E. W. Bodde, V. M. Cuijpers, L. S. Baggett, Y. Tabata, A. G. Mikos, and J. A. Jansen. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr. Cartil. 15:187–197, 2007.
Hou, T., J. Xu, X. Wu, Z. Xie, F. Luo, Z. Zhang, and L. Zeng. Umbilical cord Wharton’s Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Eng. A 15:2325–2334, 2009.
Jaiswal, N., S. E. Haynesworth, A. I. Caplan, and S. P. Bruder. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 64:295–312, 1997.
Kapur, T. A., and M. S. Shoichet. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. J. Biomed. Mater. Res. 68:235–243, 2004.
Karahuseyinoglu, S., O. Cinar, E. Kilic, F. Kara, G. G. Akay, D. O. Demiralp, A. Tukun, D. Uckan, and A. Can. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319–331, 2007.
Knapp, D. M., E. F. Helou, and R. T. Tranquillo. A fibrin or collagen gel assay for tissue cell chemotaxis: assessment of fibroblast chemotaxis to GRGDSP. Exp. Cell Res. 247:543–553, 1999.
Knippenberg, M., M. N. Helder, B. Zandieh Doulabi, P. I. J. M. Wuisman, and J. Klein-Nulend. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem. Biophys. Res. Commun. 342:902–908, 2006.
Kramer, J., C. Hegert, K. Guan, A. M. Wobus, P. K. Müller, and J. Rohwedel. Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev. 92:193–205, 2000.
Livak, K. J., and T. D. Schmittgen. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408, 2001.
Lu, L. L., Y. J. Liu, S. G. Yang, Q. J. Zhao, X. Wang, W. Gong, Z. B. Han, Z. S. Xu, Y. X. Lu, D. Liu, Z. Z. Chen, and Z. C. Han. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017–1026, 2006.
Lu, X., X. Lv, Z. Sun, and Y. Zheng. Nanocomposites of poly(l-lactide) and surface-grafted TiO2 nanoparticles: synthesis and characterization. Eur. Polym. J. 44:2476–2481, 2008.
Luiz Meirelles, L. M., T. Peltola, P. Kjellin, I. Kangasniemi, F. Currie, M. Andersson, T. Albrektsson, and A. Wennerberg. Effect of hydroxyapatite and titania nanostructures on early in vivo bone response. Clin.Implant Dentist. Rel. Res. 10:245–254, 2008.
Matthias, W., K. W. Laschke, T. Pohlemann, and M. D. Menger. Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility and vascularization. J. Biomed. Mater. Res. B 82B:494–505, 2007.
Moss, D. Alkaline phosphatase isoenzymes. Clin. Chem. 28:2007–2016, 1982.
Noël, D., D. Gazit, C. Bouquet, F. Apparailly, C. Bony, P. Plence, V. Millet, G. Turgeman, M. Perricaudet, J. Sany, and C. Jorgensen. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 22:74–85, 2004.
Petrie Aronin, C. E., K. W. Sadik, A. L. Lay, D. B. Rion, S. S. Tholpady, R. C. Ogle, and E. A. Botchwey. Comparative effects of scaffold pore size, pore volume, and total void volume on cranial bone healing patterns using microsphere-based scaffolds. J. Biomed. Mater. Res. A 89:632–641, 2009.
Phillips, J. E., K. L. Burns, J. M. Le Doux, R. E. Guldberg, and A. J. Garcia. Engineering graded tissue interfaces. Proc. Natl. Acad. Sci. USA 105:12170–12175, 2008.
Reinholt, F., K. Hultenby, A. Oldberg, and D. Heinegård. Osteopontin–a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. 87:4473–4475, 1990.
Ross, F., J. Chappel, J. Alvarez, D. Sander, W. Butler, M. Farach-Carson, K. Mintz, P. Robey, S. Teitelbaum, and D. Cheresh. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J. Biol. Chem. 268:9901–9907, 1993.
Sarugaser, R., D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23:220–229, 2005.
Scaglione, S., C. Ilengo, M. Fato, and R. Quarto. Hydroxyapatite-coated polycaprolactone wide mesh as a model of open structure for bone regeneration. Tissue Eng. A 15:155–163, 2009.
Shen, H., X. Hu, F. Yang, J. Bei, and S. Wang. An injectable scaffold: rhBMP-2-loaded poly (lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomater. 2009.
Shi, X., Y. Wang, L. Ren, Y. Gong, and D. Wang. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm. Res. 26:422–430, 2009.
Singh, M., C. Berkland, and M. S. Detamore. Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Eng. B 14:341–366, 2008.
Singh, M., N. Dormer, J. Salash, J. Christian, D. Moore, C. Berkland, and M. Detamore. Three-dimensional macroscopic scaffolds with a gradient in stiffness for functional regeneration of interfacial tissues. J. Biomed. Mater. Res. A. Available online ahead of print, 2010.
Singh, M., C. P. Morris, R. J. Ellis, M. S. Detamore, and C. Berkland. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng. C: Methods 14:299–309, 2008.
Spinella-Jaegle, S., S. Roman-Roman, C. Faucheu, F. W. Dunn, S. Kawai, S. Galléa, V. Stiot, A. M. Blanchet, B. Courtois, R. Baron, and G. Rawadi. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29:323–330, 2001.
Stokes, D., G. Liu, R. Dharmavaram, and D. Hawkins. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem. J. 360:461–470, 2001.
Torres, F. G., S. N. Nazhat, S. H. Sheikh Md Fadzullah, V. Maquet, and A. R. Boccaccini. Mechanical properties and bioactivity of porous PLGA/TiO2 nanoparticle-filled composites for tissue engineering scaffolds. Compos. Sci. Technol. 67:1139–1147, 2007.
Tracy, M. A., K. L. Ward, L. Firouzabadian, Y. Wang, N. Dong, R. Qian, and Y. Zhang. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 20:1057–1062, 1999.
Tuan, R. S., G. Boland, and R. Tuli. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res. Ther. 5:32–45, 2003.
Wang, H. S., S. C. Hung, S. T. Peng, C. C. Huang, H. M. Wei, Y. J. Guo, Y. S. Fu, M. C. Lai, and C. C. Chen. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22:1330–1337, 2004.
Wang, L., N. H. Dormer, L. Bonewald, and M. S. Detamore. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng. A. Available online ahead of print, 2010.
Wang, Y., X. Shi, L. Ren, C. Wang, and D.-A. Wang. Porous poly (lactic-co-glycolide) microsphere sintered scaffolds for tissue repair applications. Mater. Sci. Eng. C 29:2502–2507, 2009.
Wang, L., M. Singh, L. F. Bonewald, and M. S. Detamore. Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J. Tissue Eng. Regen. Med. 3:398–404, 2009.
Wang, L., I. Tran, K. Seshareddy, M. L. Weiss, and M. S. Detamore. A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng. A 15:1009–1017, 2009.
Wang, X., E. Wenk, X. Zhang, L. Meinel, G. Vunjak-Novakovic, and D. Kaplan. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J. Controlled Rel. 134:81–90, 2009.
Wu, L., and J. Ding. In vitro degradation of three-dimensional porous poly(D, L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 25:5821–5830, 2004.
Wu, K. H., B. Zhou, C. T. Yu, B. Cui, S. H. Lu, Z. C. Han, and Y. L. Liu. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann. Thorac. Surg. 83:1491–1498, 2007.
Yang, X., H. Roach, N. Clarke, S. Howdle, R. Quirk, K. Shakesheff, and R. Oreffo. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 29:523–531, 2001.
Zhang, H., and S. Hollister. Comparison of bone marrow stromal cell behaviors on poly (caprolactone) with or without surface modification: studies on cell adhesion, survival and proliferation. J. Biomater. Sci. Polym. Ed. 20:1975–1993, 2009.
Zhao, L., E. F. Burguera, H. H. K. Xu, N. Amin, H. Ryou, and D. D. Arola. Fatigue and human umbilical cord stem cell seeding characteristics of calcium phosphate-chitosan-biodegradable fiber scaffolds. Biomaterials 31:840–847, 2009.
Acknowledgments
The authors would like to express their gratitude to the Arthritis Foundation, the National Institutes of Health (NIH/NIDCR 1 R21 DE017673-01) for their support, to NIGMS/NIH Pharmaceutical Aspects of Biotechnology Training grant (T32-GM008359) for supporting N. H. Dormer, and to Dr. Xinkun Wang of the K.U. Genomics Facility for his guidance in RT–PCR.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor in Chief Kyriacos A. Athanasiou oversaw the review of this article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dormer, N.H., Singh, M., Wang, L. et al. Osteochondral Interface Tissue Engineering Using Macroscopic Gradients of Bioactive Signals. Ann Biomed Eng 38, 2167–2182 (2010). https://doi.org/10.1007/s10439-010-0028-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-010-0028-0